Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Diabetes/Metabolism Research and Reviews|February 25, 2024
Adherence to an energy-restricted Mediterranean diet is associated with the presence and burden of carotid atherosclerosis in people with type 1 diabetesTonet Serés-Noriega, Clara Viñals, Verónica Perea, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 2, 2023
Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory AnalysisTonet Serés-Noriega, Emilio Ortega, Verónica Perea, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 23, 2023
Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular riskTonet Serés-Noriega, Emilio Ortega, Marga Giménez, et al.
European Journal of Nutrition|June 21, 2021
Biomarkers of fatty acid intake are independently associated with preclinical atherosclerosis in individuals with type 1 diabetesAlex Mesa, Montserrat Cofán, Enric Esmatjes, et al.
Endocrinologia, Diabetes Y Nutricion|September 11, 2020
Results of a specific and structured program in the transition of young patients with type 1 diabetes from the paediatric center to an adult hospital. The experience of a decadeMercè Vidal Flor, Margarida Jansà I Morató, Daria Roca Espino, et al.
Antiviral Therapy|December 3, 2003
Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitorsEsteban Martínez, Pere Domingo, Esteban Ribera, et al.
Diabetes Research and Clinical Practice|July 6, 2024
Dose-Dependent association of cumulative tobacco consumption with the presence of carotid atherosclerosis in individuals with type 1 diabetesClara Solà, Clara Viñals, Tonet Serés-Noriega, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trialPeter J Raubenheimer, William C Cushman, Alvaro Avezum, et al.
European Journal of Heart Failure|September 8, 2022
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trialKelley R H Branch, Gilles R Dagenais, Alvaro Avezum, et al.
Pageof 14